Immediate Impact

1 from Science/Nature 70 hit
Sub-graph 1 of 22

Citing Papers

Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes (STRIDE): a phase 3b, double-blind, randomised, placebo-controlled trial
2025 Hit
Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
2024 Hit
1 intermediate paper

Works of Jing Wu being referenced

Efficacy and Safety of Glucagon-Like Peptide 1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Network Meta-analysis
2021
PDB31 DIRECT MEDICAL COSTS OF INCIDENT COMPLICATIONS IN PATIENTS WITH NEWLY-DIAGNOSED TYPE 2 DIABETES IN CHINA: FINDINGS FROM A MEDICAL CLAIMS DATABASE
2020

Author Peers

Author Last Decade Papers Cites
Jing Wu 529 364 275 230 225 165 2.3k
Shan Jiang 227 721 179 258 413 196 3.1k
Alex Z. Fu 565 480 345 1023 291 115 3.1k
Zoltán Vokó 293 230 393 186 340 151 2.9k
Dong Wang 215 310 514 227 674 159 2.8k
Darren Lau 264 338 270 239 581 54 2.1k
Fernando Antoñanzas 779 177 395 280 409 147 2.4k
Min Yu 141 140 277 377 195 103 1.8k
Jeff J. Guo 485 126 308 207 301 119 2.8k
T Walley 762 124 571 176 230 82 3.0k
Sehyun Kim 129 220 232 236 169 68 1.6k

All Works

Loading papers...

Rankless by CCL
2026